Altimmune Inc (ALT)
NASDAQ:ALT
US Market
Advertisement

Altimmune (ALT) Ratios

Compare
3,489 Followers

Altimmune Ratios

ALT's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, ALT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
17.18 17.26 11.31 11.17 19.16
Quick Ratio
17.18 17.26 11.30 743.75 182.12
Cash Ratio
4.86 11.13 6.51 10.41 9.64
Solvency Ratio
-2.55 -5.32 -3.89 -4.85 -2.53
Operating Cash Flow Ratio
-5.26 -6.24 -3.67 -4.28 -2.86
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 183.77M$ 193.09M$ 171.18M$ 184.40M$ 211.02M
Leverage Ratios
Debt-to-Assets Ratio
0.00 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.00 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.00 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.09 1.12 1.10 1.09
Debt Service Coverage Ratio
372.93 -2.51K -10.53K -16.90K -5.17K
Interest Coverage Ratio
395.03 -2.74K -10.97K -17.13K -5.82K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
>-0.01 0.01 0.02 0.04 0.07
Net Debt to EBITDA
0.71 1.53 1.30 1.96 2.11
Profitability Margins
Gross Profit Margin
75.00%-11.97%200.00%87.50%-309.40%
EBIT Margin
-326580.00%-20753.99%124855.88%-2201.30%-665.26%
EBITDA Margin
-430415.00%-20642.02%124120.59%-2188.80%-661.62%
Operating Profit Margin
-452310.00%-22518.54%129029.41%-2197.42%-669.50%
Pretax Profit Margin
-422980.00%-20762.21%124867.65%-2201.43%-665.38%
Net Profit Margin
-419575.00%-20762.21%124577.94%-2180.58%-599.20%
Continuous Operations Profit Margin
-324505.00%-20762.21%124577.94%-2201.41%-599.20%
Net Income Per EBT
99.19%100.00%99.77%99.05%90.05%
EBT Per EBIT
93.52%92.20%96.77%100.18%99.38%
Return on Assets (ROA)
-38.41%-41.99%-40.94%-43.94%-20.01%
Return on Equity (ROE)
-54.79%-45.57%-45.72%-48.29%-21.71%
Return on Capital Employed (ROCE)
-43.95%-48.33%-46.21%-48.31%-23.51%
Return on Invested Capital (ROIC)
-43.59%-48.21%-45.99%-47.76%-21.14%
Return on Tangible Assets
-38.41%-41.99%-43.55%-46.58%-21.11%
Earnings Yield
-22.19%-14.77%-10.97%-25.43%-16.96%
Efficiency Ratios
Receivables Turnover
0.02 0.09 -0.03 10.28 0.66
Payables Turnover
<0.01 0.23 0.01 0.27 54.73
Inventory Turnover
0.00 0.00 2.00 >-0.01 -0.02
Fixed Asset Turnover
0.06 0.42 -0.06 3.05 4.17
Asset Turnover
<0.01 <0.01 >-0.01 0.02 0.03
Working Capital Turnover Ratio
<0.01 <0.01 >-0.01 0.02 0.06
Cash Conversion Cycle
-43.03K 2.57K -39.24K -8.87M -20.79K
Days of Sales Outstanding
15.42K 4.16K -13.64K 35.50 551.76
Days of Inventory Outstanding
0.00 0.00 182.50 -8.86M -21.34K
Days of Payables Outstanding
58.45K 1.58K 25.79K 1.35K 6.67
Operating Cycle
15.42K 4.16K -13.46K -8.86M -20.79K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.74 -1.42 -1.33 -1.90 -1.34
Free Cash Flow Per Share
-0.74 -1.42 -1.34 -2.19 -1.36
CapEx Per Share
<0.01 <0.01 <0.01 0.30 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.16 1.01
Dividend Paid and CapEx Coverage Ratio
-6.64K -1.61K -496.71 -6.35 -100.57
Capital Expenditure Coverage Ratio
-6.64K -1.61K -496.71 -6.35 -100.57
Operating Cash Flow Coverage Ratio
0.00 -112.98 -55.68 -50.97 -18.87
Operating Cash Flow to Sales Ratio
-3.32K -177.96 920.38 -17.74 -4.21
Free Cash Flow Yield
-17.78%-12.66%-8.12%-23.94%-12.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.48 -6.77 -9.11 -3.93 -5.90
Price-to-Sales (P/S) Ratio
18.56K 1.41K -11.35K 85.74 35.33
Price-to-Book (P/B) Ratio
2.03 3.09 4.17 1.90 1.28
Price-to-Free Cash Flow (P/FCF) Ratio
-5.59 -7.90 -12.31 -4.18 -8.31
Price-to-Operating Cash Flow Ratio
-5.67 -7.90 -12.33 -4.83 -8.40
Price-to-Earnings Growth (PEG) Ratio
-0.48 0.82 0.41 -0.18 -0.26
Price-to-Fair Value
2.03 3.09 4.17 1.90 1.28
Enterprise Value Multiple
-3.60 -5.28 -7.84 -1.96 -3.23
Enterprise Value
312.09M 464.58M 661.97M 189.39M 175.09M
EV to EBITDA
-3.63 -5.28 -7.84 -1.96 -3.23
EV to Sales
15.60K 1.09K -9.73K 42.94 21.39
EV to Free Cash Flow
-4.70 -6.12 -10.56 -2.09 -5.03
EV to Operating Cash Flow
-4.70 -6.13 -10.58 -2.42 -5.08
Tangible Book Value Per Share
2.08 3.65 3.68 4.52 8.31
Shareholders’ Equity Per Share
2.08 3.65 3.95 4.82 8.81
Tax and Other Ratios
Effective Tax Rate
<0.01 0.00 <0.01 <0.01 0.10
Revenue Per Share
<0.01 <0.01 >-0.01 0.11 0.32
Net Income Per Share
-0.94 -1.66 -1.81 -2.33 -1.91
Tax Burden
0.99 1.00 1.00 0.99 0.90
Interest Burden
1.30 1.00 1.00 1.00 1.00
Research & Development to Revenue
3.39K 154.46 -1.04K 16.90 6.08
SG&A to Revenue
1.13K 42.58 -251.97 3.49 1.61
Stock-Based Compensation to Revenue
724.45 24.98 -119.13 1.25 0.31
Income Quality
0.79 0.86 0.74 0.81 0.70
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis